{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:02:23Z","timestamp":1783533743726,"version":"3.55.0"},"reference-count":40,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12821","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:13:53Z","timestamp":1739279633000},"source":"Crossref","is-referenced-by-count":3,"title":["Proteasome inhibitor MG132 modulates signal transduction pathways in ELT3 uterine leiomyoma cells"],"prefix":"10.3892","volume":"29","author":[{"given":"Hosouk","family":"Joung","sequence":"first","affiliation":[{"name":"Research Institute of Medical Sciences, Chonnam National University Medical School, Hwasun, Jeollanam\u2011do 58128, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Ra","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chosun University Hospital, Gwangju 61453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chosun University Hospital, Gwangju 61453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunju","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Chosun University Hospital, Gwangju 61453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"16043","key":"key20250401110508_b1-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"key20250401110508_b2-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"key20250401110508_b3-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/s0015-0282(02)03366-6","article-title":"Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma","volume":"78","author":"Cermik","year":"2002","journal-title":"Fertil Steril"},{"key":"key20250401110508_b4-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5468\/ogs.23143","article-title":"Association between serum vitamin D status and uterine leiomyomas: A case-control study","volume":"67","author":"Okoro","year":"2024","journal-title":"Obstet Gynecol Sci"},{"key":"key20250401110508_b5-ETM-29-4-12821","first-page":"100","article-title":"Uterine fibroids: Diagnosis and treatment","volume":"95","author":"De La Cruz","year":"2017","journal-title":"Am Fam Physician"},{"key":"key20250401110508_b6-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5468\/ogs.2017.60.1.69","article-title":"Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet Gynecol Sci"},{"issue":"633180","key":"key20250401110508_b7-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633180","article-title":"Understanding the impact of uterine fibroids on human endometrium function","volume":"9","author":"Navarro","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20250401110508_b8-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.2174\/1381612826666210101152820","article-title":"Highlights on medical treatment of uterine fibroids","volume":"27","author":"Angioni","year":"2021","journal-title":"Curr Pharm Des"},{"key":"key20250401110508_b9-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/GCO.0000000000000880","article-title":"New treatment options for nonsurgical management of uterine fibroids","volume":"35","author":"Lee","year":"2023","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key20250401110508_b10-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/IJWH.S15710","article-title":"Current and emerging treatments for uterine myoma-an update","volume":"3","author":"Duhan","year":"2011","journal-title":"Int J Womens Health"},{"key":"key20250401110508_b11-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5468\/ogs.2019.62.4.258","article-title":"Clinical characteristics of patients with leiomyoma who undergo surgery after high intensity focused ultrasound (HIFU)","volume":"62","author":"Choe","year":"2019","journal-title":"Obstet Gynecol Sci"},{"issue":"55","key":"key20250401110508_b12-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01627-y","article-title":"Comparison of two invasive non-surgical treatment options for uterine myomas: Uterine artery embolization and magnetic resonance guided high intensity focused ultrasound-systematic review","volume":"22","author":"Yerezhepbayeva","year":"2022","journal-title":"BMC Womens Health"},{"key":"key20250401110508_b13-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/annonc\/mdj131","article-title":"Bortezomib (VELCADE) in metastatic breast cancer: Pharmacodynamics, biological effects, and prediction of clinical benefits","volume":"17","author":"Yang","year":"2006","journal-title":"Ann Oncol"},{"key":"key20250401110508_b14-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/07357900701506573","article-title":"A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience","volume":"25","author":"Engel","year":"2007","journal-title":"Cancer Invest"},{"key":"key20250401110508_b15-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.ejca.2008.05.022","article-title":"Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours","volume":"44","author":"Cresta","year":"2008","journal-title":"Eur J Cancer"},{"key":"key20250401110508_b16-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2007.08.071","article-title":"Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer","volume":"108","author":"Ramirez","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20250401110508_b17-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/13543780903002074","article-title":"Clinical development of novel proteasome inhibitors for cancer treatment","volume":"18","author":"Yang","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"key20250401110508_b18-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0962-8924(98)01346-4","article-title":"Proteasome inhibitors: Valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol"},{"key":"key20250401110508_b19-ETM-29-4-12821","first-page":"215","article-title":"The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH","volume":"22","author":"Han","year":"2009","journal-title":"Oncol Rep"},{"key":"key20250401110508_b20-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","article-title":"MG132, a proteasome inhibitor, induces apoptosis in tumor cells","volume":"9","author":"Guo","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5808","key":"key20250401110508_b21-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09763-z","article-title":"Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells","volume":"12","author":"Tarj\u00e1nyi","year":"2022","journal-title":"Sci Rep"},{"key":"key20250401110508_b22-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.canlet.2005.11.033","article-title":"Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells","volume":"243","author":"Yang","year":"2006","journal-title":"Cancer Lett"},{"key":"key20250401110508_b23-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/aps.2014.52","article-title":"MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression","volume":"35","author":"Yan","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"key20250401110508_b24-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"294","DOI":"10.12659\/msm.908139","article-title":"Proteasome inhibitor carbobenzoxy-L-Leucyl-L-leucyl-L-leucinal (MG132) enhances therapeutic effect of paclitaxel on breast cancer by inhibiting nuclear factor (NF)-\u03baB signaling","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"key":"key20250401110508_b25-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0960327109358733","article-title":"MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level","volume":"29","author":"Han","year":"2010","journal-title":"Hum Exp Toxicol"},{"key":"key20250401110508_b26-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.05.006","article-title":"MG132 enhances neurite outgrowth in neurons overexpressing mutant TAR DNA-binding protein-43 via increase of HO-1","volume":"1397","author":"Duan","year":"2011","journal-title":"Brain Res"},{"issue":"97","key":"key20250401110508_b27-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8756","article-title":"2-D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells","volume":"52","author":"Joung","year":"2024","journal-title":"Oncol Rep"},{"issue":"1270256","key":"key20250401110508_b28-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1270256","article-title":"Oxidative stress and mitochondrial damage in neurodegenerative diseases: From molecular mechanisms to targeted therapies","volume":"2020","author":"Cenini","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"key20250401110508_b29-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/acs.chemrestox.9b00152","article-title":"N-acetylcysteine: Antioxidant, aldehyde scavenger, and more","volume":"32","author":"Zhitkovich","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"key20250401110508_b30-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","article-title":"Autophagy in healthy aging and disease","volume":"1","author":"Aman","year":"2021","journal-title":"Nat Aging"},{"key":"key20250401110508_b31-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2567.2008.02806.x","article-title":"MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: Involvement of nuclear factor-kappaB and activator protein-1","volume":"124","author":"Ortiz-Lazareno","year":"2008","journal-title":"Immunology"},{"key":"key20250401110508_b32-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.bcp.2011.07.085","article-title":"Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells","volume":"82","author":"Park","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"e417","key":"key20250401110508_b33-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.157","article-title":"Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation","volume":"3","author":"Westerberg","year":"2012","journal-title":"Cell Death Dis"},{"key":"key20250401110508_b34-ETM-29-4-12821","first-page":"935","article-title":"Influence of p53 and p21Waf1 expression on G2\/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors","volume":"24","author":"Kim","year":"2004","journal-title":"Int J Oncol"},{"key":"key20250401110508_b35-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s10637-012-9804-z","article-title":"Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K\/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1\/2 signaling","volume":"30","author":"Zanotto-Filho","year":"2012","journal-title":"Invest New Drugs"},{"key":"key20250401110508_b36-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s12276-020-0455-4","article-title":"Autophagy as a decisive process for cell death","volume":"52","author":"Jung","year":"2020","journal-title":"Exp Mol Med"},{"issue":"648","key":"key20250401110508_b37-ETM-29-4-12821","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: Regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"key20250401110508_b38-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3892\/mmr.2015.4599","article-title":"Induction of autophagy by the MG-132 proteasome inhibitor is associated with endoplasmic reticulum stress in MCF-7 cells","volume":"13","author":"Bao","year":"2016","journal-title":"Mol Med Rep"},{"key":"key20250401110508_b39-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1038\/s41388-019-0675-z","article-title":"Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"key20250401110508_b40-ETM-29-4-12821","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1007\/s12035-016-0260-1","article-title":"A central role for phosphorylated p38\u03b1 in linking proteasome inhibition-induced apoptosis and autophagy","volume":"54","author":"Guo","year":"2017","journal-title":"Mol Neurobiol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T08:38:12Z","timestamp":1743496692000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12821","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"article-number":"71"}}